Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 15, 2008
[Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin]V K Bochkarev, E S Teleshova, S A Siuniakov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 11, 2001
[Clinical study of the selective anxiolytic agent afobazol]G G Neznamov, S A Siuniakov, D V Chumakov, et al.
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)|January 1, 1987
[Activation of lipid peroxidation in the bodies of schizophrenic and manic-depressive patients]L L Prilipko, A N Erin, B S Beliaev, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|July 28, 2012
[Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types]G G Neznamov, V K Bochkarev, M A Reutova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|September 13, 2001
[Therapeutic action and efficiency of fevarin (fluvoxamine) in patients with non-psychotic anxious and apathic-adynamic depressions]G G Neznamov, S A Siuniakov, E S Teleshova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|February 1, 2012
[Self-evaluation of single test doses and objective indices of ladasten vs. placebo efficacy in neurasthenic patients]M A Reutova, S A Siuniakov, T S Siuniakov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|May 25, 2002
[Effect of tanakan on psychophysiological status of patients with asthenic disorders]G G Neznamov, E S Teleshova, S A Siuniakov, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|May 16, 2009
[Therapeutic effect and pharmacokinetics of transdermal phenazepam preparation in patients with different anxiety disorders]O A Dorofeeva, S A Siuniakov, V P Zherdev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 4, 2009
[Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)]G G Neznamov, S A Siuniakov, S E Teleshova, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|September 6, 2013
[Clinic pharmacokinetics of a new original antipsychotic drug Dilept]R V Shevchenko, A A Litvin, G B Kolyvanov, et al.
Pageof 3